Literature DB >> 12590414

Methods for categorizing a prognostic variable in a multivariable setting.

Madhu Mazumdar1, Alex Smith, Jennifer Bacik.   

Abstract

The literature is filled with examples of categorization of a continuous prognostic variable in a univariable setting followed by the addition of this categorical variable to an existing multivariable model. Typically, an "optimal" cutpoint for a new prognostic variable is obtained through a systematic search relating the variable to the outcome in an univariable manner. The corresponding categorical variable is then fitted in a multivariable model along with other already established prognostic covariates to assess the additional value of the new variable. This prompts the question whether the cutpoint search should have been performed in the same multivariable setting where it will ultimately be used. In this paper, we extend the univariable cutpoint search methods (split-sample approach and two-fold cross-validation approach) to the multivariable setting using -2 x log-likelihood statistic as the correlative measure. A Monte Carlo simulation study demonstrates that both methods are more efficient in detecting the true cutpoint and in estimating the effect size under the multivariable setting as opposed to the univariable setting. The cross-validation method performs better than the split-sample method in univariable as well as multivariable scenarios. For the cross-validation method in the multivariable setting, there is still a substantial loss of power when a cutpoint model is used in cases where there is a continuous relationship between the covariate and the outcome. An example is provided to illustrate the value of the multivariable cross-validation approach. Copyright 2003 John Wiley & Sons, Ltd.

Mesh:

Year:  2003        PMID: 12590414     DOI: 10.1002/sim.1333

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  41 in total

1.  Adhesive postoperative small bowel obstruction: incidence and risk factors of recurrence after surgical treatment: a multicenter prospective study.

Authors:  Jean-Jacques Duron; Nathalie Jourdan-Da Silva; Sophie Tezenas du Montcel; Anne Berger; Fabrice Muscari; Henri Hennet; Michel Veyrieres; Jean Marie Hay
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

2.  Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study.

Authors:  Zubin Punthakee; Pilar Paniagua Iglesias; Pablo Alonso-Coello; Ignasi Gich; Inmaculada India; Germán Malaga; Ruben Diaz Jover; Hertzel C Gerstein; P J Devereaux
Journal:  Lancet Diabetes Endocrinol       Date:  2018-07-26       Impact factor: 32.069

3.  Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.

Authors:  Ann Y Lee; Narasimhan P Agaram; Li-Xuan Qin; Deborah Kuk; Christina Curtin; Murray F Brennan; Samuel Singer
Journal:  Ann Surg Oncol       Date:  2016-01-12       Impact factor: 5.344

4.  Optimal cutoffs of obesity measures in relation to cancer risk in postmenopausal women in the Women's Health Initiative Study.

Authors:  Moonseong Heo; Geoffrey C Kabat; Howard D Strickler; Juan Lin; Lifang Hou; Marcia L Stefanick; Garnet L Anderson; Thomas E Rohan
Journal:  J Womens Health (Larchmt)       Date:  2015-01-14       Impact factor: 2.681

5.  Model-robust inference for continuous threshold regression models.

Authors:  Youyi Fong; Chongzhi Di; Ying Huang; Peter B Gilbert
Journal:  Biometrics       Date:  2016-11-17       Impact factor: 2.571

6.  Post-operative high sensitivity troponin T (hsTnT): toward an extending use for diagnosis and management of myocardial injury after noncardiac surgery?

Authors:  Xavier Chapalain; Olivier Huet
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

7.  Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.

Authors:  Yoshihiro Suzuki; Takashi Oshima; Kazue Yoshihara; Kentaro Sakamaki; Toru Aoyama; Haruhiko Cho; Manabu Shiozawa; Takaki Yoshikawa; Yasushi Rino; Toshio Imada; Munetaka Masuda
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

8.  Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past.

Authors:  Roberto Santambrogio; Enrico Opocher; Mara Costa; Savino Bruno; Andrea Pisani Ceretti; Gian Paolo Spina
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.

Authors:  James O Park; Li-Xuan Qin; Francesco P Prete; Cristina Antonescu; Murray F Brennan; Samuel Singer
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

10.  Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.

Authors:  Koji Numata; Takashi Oshima; Kentaro Sakamaki; Kazue Yoshihara; Toru Aoyama; Tsutomu Hayashi; Takanobu Yamada; Tsutomu Sato; Haruhiko Cho; Manabu Shiozawa; Takaki Yoshikawa; Yasushi Rino; Chikara Kunisaki; Makoto Akaike; Toshio Imada; Munetaka Masuda
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-03       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.